Pulmonary arterial hypertension in ANCA-associated vasculitis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 23, Issue 3, 2006, Pages 223-228

  Launay, David ^a   Souza, Rogério ^b   Guillevin, Loïc ^c   Hachulla, Éric ^a   Pouchot, Jacques ^d   Simonneau, Gérald ^b   Humbert, Marc ^b,e  

^a UNIV LILLE   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Assistance Publique Hôpitaux de Paris ^*  (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Anti neutrophil cytoplasmic antibodies; Microscopic polyangiitis; Pulmonary arterial hypertension; Vasculitis; Wegener's granulomatosis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANCA ASSOCIATED VASCULITIS; ANTIBODY BLOOD LEVEL; ARTICLE; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; LUNG ARTERY; LUNG BIOPSY; MALE; MEDICAL DOCUMENTATION; MICROSCOPIC POLYANGIITIS; ONSET AGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; WEGENER GRANULOMATOSIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; RECURRENCE; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 35348988639     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rubin LJ: Primary pulmonary hypertension. N Engl J Med 1997; 336: 111-7.
2. Humbert M, Sitbon O, Simonneau G: Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425-36.
3. Archer S, Rich S: Primary Pulmonary Hypertension: A Vascular Biology and Translational Research "Work in Progress". Circulation 2000; 102: 2781-91.
4. Humbert M, Nunes H, Sitbon O, Parent F, Herve P, Simonneau G: Risk factors for pulmonary arterial hypertension. Clin Chest Med 2001; 22: 459-75.
5. Isern RA, Yaneva M, Weiner E, et al: Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med 1992; 93: 307-12.
6. Humbert M, Monti G, Brenot F, et al: Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995; 151: 1628-31.
7. Humbert M, Monti G, Fartoukh M, et al. Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HlV seronegative patients. Eur Respir J 1998; 11: 554-9.
8. Fartoukh M, Emilie D, Le Gall C, Monti G, Simonneau G, Humbert M: Chemokine macrophage inflammatory protein-1 alpha mRNA expression in lung biopsy specimens of primary pulmonary hypertension. Chest 1998; 114; 50S-1S.
9. Dorfmuller P, Zarka V, Durand-Gasselin I, et al: Chemokine RANTES in severe pulmonary arterial hypertension. Am J Respir Crit Care Med 2002; 165: 534-9.
10. Balabanian K, Foussat A, Dorfmuller P, et al: CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Cht Care Med 2002; 165: 1419-25.
11. Tuder RM, Grube E, Badesch D, Voelkel NF. Exuberant endothelial cell growth and element of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994; 144: 275-85.
12. Sanchez O, Humbert M, Sitbon O, Simonneau G: Treatment of pulmonary hypertension secondary to connective tissue diseases. Thorax 1999; 54: 273-7.
13. Nunes H, Ramos JM, Valerio L, Abreu J, Bernardes L, Salomao S: Pulmonary artery involvement in Takayasu arteritis. A case of right ventricular failure as presentation form. Rev Port Cardiol 1992; 11: 775-80.
14. Bletry O, Kieffer E, Herson S, et al: Severe pulmonary artery involvement of Takayasu arteritis. 3 cases and review of the literature. Arch Mal Coeur Vaiss 1991; 84: 817-22.
15. Baydur A, Mongan ES, Slager UT: Acute respiratory failure and pulmonary arteritis without parenchymal involvement; demonstration in a patient with rheumatoid arthritis. Chest 1979; 75: 518-20.
16. Marette P, Molle B, Mas JL, et al: Angina without involvement of large coronary trunks and precapillary pulmonary hypertension in a patient with periarteritis nodosa. Ann Cardiol Angeiol 1989; 38: 305-8.
17. Comparato E, Toso M: A case of polyarteritis nodosa associated with pulmonary hypertension. Minerva Med 1977; 68: 2963-70.
18. Uchiyama M, Shishihara K, Tanabe N, et al: A case of idiopathic pulmonary arteritis with positive anti- myeloperoxidase antibodies. Nihon Kyobu Shikkan Gakkai Zasshi 1995; 33: 569-75.
19. Doyle DJ, Fanning NF, Silke CS, et al: Wegener's granulomatosis of the main pulmonary arteries: imaging findings. Clin Radiol 2003; 58: 329-31.
20. Leavitt R, Fauci AC, Bloch DA, et al: The ACR 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1980; 33: 1101-7.
21. Blanco A, Solis P, Gomez S, Valbuena C, Telleria JJ: Antineutrophil cytoplasmic antibodies (ANCA) in idiopathic pulmonary hemosiderosis. Pediatr Allergy Immunol 1994; 5: 235-9.
22. Trimarchi M, Nicolai P, Lombardi D, Facchetti F, Morassi ML, Maroldi R: Sinonasal osteocartilaginous necrosis in cocaine abusers: experience in 25 patients. Am J Rhinol 2003; 17: 33-43.
23. Yakel DLJ, Eisenberg MJ: Pulmonary artery hypertension in chronic intravenous cocaine users. Am Heart J 1995; 130: 398-9.
24. Sitbon O, Humbert M, Jais X, et al: Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005; 111: 3105-11.
25. Denton CP, Cailes JB, Phillips GD, Wells AU, Black CM, Bois RM: Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 1997; 36: 239-43.
26. Cavero MA, Maicas C, Silva L: Takayasu's disease causing pulmonary hypertension and right heart failure. Am Heart J 1994; 127: 450-1.
27. Chassagne P, Gligorov J, Dominique S: Pulmonary artery obstruction and giant cell arteritis. Ann Intern Med 2005; 122: 732.
28. Jarousse B, Even P: Angéite granulomateuses allergiques de Churg et Strauss, granulomatose de Wegener et vascularites pulmonaires apparentées. In: Flammarion, editor. Les maladies systémiques. Paris: 1995: 605-54.
29. Carrington V, Liebow AA: Limited forms of angiitis and granulomatosis of Wegener's type. Am J Med 1966; 41: 497.
30. Merkel PA, Lo GH, Holbrook JT, et al: Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 2005; 142: 620-6.
31. Clark T, Hoffman GS: Pulmonary artery involvement in Wegener's granulomatosis. Clin Exp Rheumatol 2003; 21: S124-S126.
32. Galie N, Torbicki A, Barst R, et al: Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004; 25: 2243-78.
33. Wagenaar SS, van den Bosch JM, Westermann CJ, et al: Isolated granulomatous giant cell vasculitis of the pulmonary elastic arteries. Arch Pathol Lab Med 1986; 110: 962-4.
34. Perros F, Dorfmuller P, Humbert M: Current insights on the pathogenesis of pulmonary arterial hypertension. Semin Respir Crit Care Med 2005; 26: 355-64.